Preoperative MRI Improves Prediction of Extensive Occult Axillary Lymph Node Metastases in Breast Cancer Patients with a Positive Sentinel Lymph Node Biopsy

Academic Radiology

Volumn 21, Issue 1, 2014, Pages 92-98

  Loiselle, Christopher ^a,d   Eby, Peter R ^b   Kim, Janice N ^a   Calhoun, Kristine E ^a   Allison, Kimberly H ^a,e   Gadi, Vijayakrishna K ^a,c   Peacock, Sue ^a   Storer, Barry E ^c   Mankoff, David A ^a,f   Partridge, Savannah C ^a   Lehman, Constance D ^a  

^a UNIVERSITY OF WASHINGTON MEDICAL CENTER   (United States)

^b VIRGINIA MASON MEDICAL CENTER   (United States)

^c USA   (United States)

^d SWEDISH MEDICAL CENTER   (United States)

^e STANFORD UNIVERSITY MEDICAL CENTER   (United States)

^f UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

Axilla; Breast cancer; MRI; Radiation; Sentinel lymph node

Indexed keywords

ESTROGEN RECEPTOR; PROGESTERONE RECEPTOR;

ARTICLE; AXILLARY LYMPH NODE; BREAST CANCER; CLINICAL ARTICLE; FEMALE; HUMAN; HUMAN TISSUE; LYMPH NODE DISSECTION; MAJOR CLINICAL STUDY; MEDICAL RECORD REVIEW; NUCLEAR MAGNETIC RESONANCE IMAGING; PARTIAL MASTECTOMY; PREOPERATIVE CARE; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SENTINEL LYMPH NODE BIOPSY; SENTINEL LYMPH NODE METASTASIS;

AXILLA; BREAST CANCER; MRI; RADIATION; SENTINEL LYMPH NODE;

ADULT; AGED; AXILLA; BREAST NEOPLASMS; FEMALE; HUMANS; LYMPH NODES; LYMPHATIC METASTASIS; MAGNETIC RESONANCE IMAGING; MIDDLE AGED; NEOPLASMS, UNKNOWN PRIMARY; OBSERVER VARIATION; PREDICTIVE VALUE OF TESTS; PREOPERATIVE CARE; PROGNOSIS; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY; SENTINEL LYMPH NODE BIOPSY;

EID: 84890245509     PISSN: 10766332     EISSN: 18784046     Source Type: Journal    
DOI: 10.1016/j.acra.2013.10.001     Document Type: Article

References (36)

1. Krag D.N., Anderson S.J., Julian T.B., et al. Sentinel-lymph-node resection compared with conventional axillary-lymph-node dissection in clinically node-negative patients with breast cancer: overall survival findings from the NSABP B-32 randomised phase 3 trial. Lancet Oncol 2010, 11:927-933.
2. Giuliano A.E., McCall L., Beitsch P., et al. Locoregional recurrence after sentinel lymph node dissection with or without axillary dissection in patients with sentinel lymph node metastases: the American College of Surgeons Oncology Group Z0011 randomized trial. Ann Surg 2010, 252:426-432.
3. Giuliano A.E., Hunt K.K., Ballman K.V., et al. Axillary dissection vs no axillary dissection in women with invasive breast cancer and sentinel node metastasis: a randomized clinical trial. JAMA 2011, 305:569-575.
4. Giuliano A.E., Chung A.P. Long-term follow-up confirms the oncologic safety of sentinel node biopsy without axillary dissection in node-negative breast cancer patients. Ann Surg 2010, 251:601-603.
5. Van Zee K.J., Manasseh D.M., Bevilacqua J.L., et al. A nomogram for predicting the likelihood of additional nodal metastases in breast cancer patients with a positive sentinel node biopsy. Ann Surg Oncol 2003, 10:1140-1151.
6. Park J., Fey J.V., Naik A.M., et al. A declining rate of completion axillary dissection in sentinel lymph node-positive breast cancer patients is associated with the use of a multivariate nomogram. Ann Surg 2007, 245:462-468.
7. Veronesi U., Orecchia R., Zurrida S., et al. Avoiding axillary dissection in breast cancer surgery: a randomized trial to assess the role of axillary radiotherapy. Ann Oncol 2005, 16:383-388.
8. Kuehn T., Klauss W., Darsow M., et al. Long-term morbidity following axillary dissection in breast cancer patients-clinical assessment, significance for life quality and the impact of demographic, oncologic and therapeutic factors. Breast Cancer Res Treat 2000, 64:275-286.
9. Schijven M.P., Vingerhoets A.J., Rutten H.J., et al. Comparison of morbidity between axillary lymph node dissection and sentinel node biopsy. Eur J Surg Oncol 2003, 29:341-350.
10. Norman S.A., Localio A.R., Potashnik S.L., et al. Lymphedema in breast cancer survivors: incidence, degree, time course, treatment, and symptoms. J Clin Oncol 2009, 27:390-397.
11. Fisher B., Jeong J.H., Anderson S., et al. Twenty-five-year follow-up of a randomized trial comparing radical mastectomy, total mastectomy, and total mastectomy followed by irradiation. N Engl J Med 2002, 347:567-575.
12. Fowble B., Gray R., Gilchrist K., et al. Identification of a subgroup of patients with breast cancer and histologically positive axillary nodes receiving adjuvant chemotherapy who may benefit from postoperative radiotherapy. J Clin Oncol 1988, 6:1107-1117.
13. Katz A., Smith B.L., Golshan M., et al. Nomogram for the prediction of having four or more involved nodes for sentinel lymph node-positive breast cancer. J Clin Oncol 2008, 26:2093-2098.
14. Loiselle C.R., Eby P.R., DeMartini W.B., et al. Dynamic contrast-enhanced MRI kinetics of invasive breast cancer: a potential prognostic marker for radiation therapy. Int J Radiat Oncol Biol Phys 2010, 76:1314-1319.
15. Tuncbilek N., Karakas H.M., Okten O.O. Dynamic magnetic resonance imaging in determining histopathological prognostic factors of invasive breast cancers. Eur J Radiol 2005, 53:199-205.
16. Mussurakis S., Buckley D.L., Horsman A. Prediction of axillary lymph node status in invasive breast cancer with dynamic contrast-enhanced MR imaging. Radiology 1997, 203:317-321.
17. Partridge S.C., Gibbs J.E., Lu Y., et al. MRI measurements of breast tumor volume predict response to neoadjuvant chemotherapy and recurrence-free survival. AJR Am J Roentgenol 2005, 184:1774-1781.
18. Marinovich M.L., Sardanelli F., Ciatto S., et al. Early prediction of pathologic response to neoadjuvant therapy in breast cancer: systematic review of the accuracy of MRI. Breast 2012, 21:669-677.
19. Partridge S.C., DeMartini W.B., Kurland B.F., et al. Quantitative diffusion-weighted imaging as an adjunct to conventional breast MRI for improved positive predictive value. AJR Am J Roentgenol 2009, 193:1716-1722.
20. Wang L.C., DeMartini W.B., Partridge S.C., et al. MRI-detected suspicious breast lesions: predictive values of kinetic features measured by computer-aided evaluation. AJR Am J Roentgenol 2009, 193:826-831.
21. Eby P.R., Partridge S.C., White S.W., et al. Metabolic and vascular features of dynamic contrast-enhanced breast magnetic resonance imaging and (15)O-water positron emission tomography blood flow in breast cancer. Acad Radiol 2008, 15:1246-1254.
22. Eby P.R., DeMartini W.B., Gutierrez R.L., et al. Characteristics of probably benign breast MRI lesions. AJR Am J Roentgenol 2009, 193:861-867.
23. American College of Radiology Breast Magnetic Resonance Imaging (MRI) Accreditation Program. Available at: Accessed August 30, 2013. http://www.acr.org/Quality-Safety/Accreditation/BreastMRI.
24. Werkoff G., Lambaudie E., Fondrinier E., et al. Prospective multicenter comparison of models to predict four or more involved axillary lymph nodes in patients with breast cancer with one to three metastatic sentinel lymph nodes. J Clin Oncol 2009, 27:5707-5712.
25. Kvistad K.A., Rydland J., Smethurst H.B., et al. Axillary lymph node metastases in breast cancer: preoperative detection with dynamic contrast-enhanced MRI. Eur Radiol 2000, 10:1464-1471.
26. Scaranelo A.M., Eiada R., Jacks L.M., et al. Accuracy of unenhanced MR imaging in the detection of axillary lymph node metastasis: study of reproducibility and reliability. Radiology 2012, 262:425-434.
27. He N., Xie C., Wei W., et al. A new, preoperative, MRI-based scoring system for diagnosing malignant axillary lymph nodes in women evaluated for breast cancer. Eur J Radiol 2012, 81:2602-2612.
28. Zahra M.A., Hollingsworth K.G., Sala E., et al. Dynamic contrast-enhanced MRI as a predictor of tumour response to radiotherapy. Lancet Oncol 2007, 8:63-74.
29. Esserman L., Hylton N., George T., et al. Contrast-enhanced magnetic resonance imaging to assess tumor histopathology and angiogenesis in breast carcinoma. Breast J 1999, 5:13-21.
30. Buadu L.D., Murakami J., Murayama S., et al. Breast lesions: correlation of contrast medium enhancement patterns on MR images with histopathologic findings and tumor angiogenesis. Radiology 1996, 200:639-649.
31. Stomper P.C., Winston J.S., Herman S., et al. Angiogenesis and dynamic MR imaging gadolinium enhancement of malignant and benign breast lesions. Breast Cancer Res Treat 1997, 45:39-46.
32. Hulka C.A., Edmister W.B., Smith B.L., et al. Dynamic echo-planar imaging of the breast: experience in diagnosing breast carcinoma and correlation with tumor angiogenesis. Radiology 1997, 205:837-842.
33. Matsubayashi R., Matsuo Y., Edakuni G., et al. Breast masses with peripheral rim enhancement on dynamic contrast-enhanced MR images: correlation of MR findings with histologic features and expression of growth factors. Radiology 2000, 217:841-848.
34. Bartella L., Morris E.A., Dershaw D.D., et al. Proton MR spectroscopy with choline peak as malignancy marker improves positive predictive value for breast cancer diagnosis: preliminary study. Radiology 2006, 239:686-692.
35. Turnbull L., Brown S., Harvey I., et al. Comparative effectiveness of MRI in breast cancer (COMICE) trial: a randomised controlled trial. Lancet 2010, 375:563-571.
36. Turnbull L.W., Brown S.R., Olivier C., et al. Multicentre randomised controlled trial examining the cost-effectiveness of contrast-enhanced high field magnetic resonance imaging in women with primary breast cancer scheduled for wide local excision (COMICE). Health Technol Assess 2010, 14:1-182.